Showing 41 - 60 results of 93 for search '(( significantly increased decrease ) OR ( significant ((all decrease) OR (fold decrease)) ))~', query time: 0.44s Refine Results
  1. 41
  2. 42

    Validation of model predictions of growth during infusion of hypertrophic agonists with and without receptor blockers. by Johane H. Bracamonte (12883844)

    Published 2025
    “…By contrast, the model prediction of nearly equal likelihood that ERA increases or decreases NE-induced growth appears to contradict a significant reported decrease in the only available experimental study [<a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1012390#pcbi.1012390.ref121" target="_blank">121</a>]. …”
  3. 43

    Osteogenic Potential and Long-Term Enzymatic Biodegradation of PHB-based Scaffolds with Composite Magnetic Nanofillers in a Magnetic Field by Lada E. Shlapakova (13200592)

    Published 2024
    “…Six-month biodegradation caused a reduction in surface potential (1.5-fold) and in a vertical piezoresponse (3.5-fold) of the Fe<sub>3</sub>O<sub>4</sub>–GO scaffold because of a decrease in the PHB β-phase content. …”
  4. 44
  5. 45
  6. 46

    The relationship between HBV antigens deposition in kidneys and renal prognosis in IgA nephropathy patients infected with HBV by Yun Guo (135103)

    Published 2024
    “…The primary outcome was a composite of 30% decrease in eGFR from the baseline, kidney failure and all-cause mortality. …”
  7. 47

    Table 1_Nano-elicitation strategy to improve specialized metabolite pathways in plant cell suspension culture.docx by Kamran Ashraf (3400700)

    Published 2025
    “…A linear decrease in all reactive oxygen species (ROS) attributes, such as H<sub>2</sub>O<sub>2</sub> (4.65%) and O<sub>2</sub><sup>-</sup> (22.81%), was observed as the NPs concentration in the culture media was increased to the T2 group (20 mg L<sup>-1</sup>). …”
  8. 48

    Table 2_The hemoglobin, albumin, lymphocyte, and platelet score as a useful predictor for mortality in older patients with hip fracture.docx by Zhicong Wang (810566)

    Published 2025
    “…For each unit increase in the HALP score, there was a significant decrease in 90-day mortality by 1.1% and in overall mortality by 1.0% (all p < 0.05). …”
  9. 49

    Table 3_The hemoglobin, albumin, lymphocyte, and platelet score as a useful predictor for mortality in older patients with hip fracture.docx by Zhicong Wang (810566)

    Published 2025
    “…For each unit increase in the HALP score, there was a significant decrease in 90-day mortality by 1.1% and in overall mortality by 1.0% (all p < 0.05). …”
  10. 50

    Table 4_The hemoglobin, albumin, lymphocyte, and platelet score as a useful predictor for mortality in older patients with hip fracture.docx by Zhicong Wang (810566)

    Published 2025
    “…For each unit increase in the HALP score, there was a significant decrease in 90-day mortality by 1.1% and in overall mortality by 1.0% (all p < 0.05). …”
  11. 51

    Image 1_The hemoglobin, albumin, lymphocyte, and platelet score as a useful predictor for mortality in older patients with hip fracture.jpeg by Zhicong Wang (810566)

    Published 2025
    “…For each unit increase in the HALP score, there was a significant decrease in 90-day mortality by 1.1% and in overall mortality by 1.0% (all p < 0.05). …”
  12. 52

    Table 1_The hemoglobin, albumin, lymphocyte, and platelet score as a useful predictor for mortality in older patients with hip fracture.docx by Zhicong Wang (810566)

    Published 2025
    “…For each unit increase in the HALP score, there was a significant decrease in 90-day mortality by 1.1% and in overall mortality by 1.0% (all p < 0.05). …”
  13. 53

    Image 2_The hemoglobin, albumin, lymphocyte, and platelet score as a useful predictor for mortality in older patients with hip fracture.jpeg by Zhicong Wang (810566)

    Published 2025
    “…For each unit increase in the HALP score, there was a significant decrease in 90-day mortality by 1.1% and in overall mortality by 1.0% (all p < 0.05). …”
  14. 54

    Table 1_Dynamic decline in estimated glomerular filtration rate associated with in-hospital mortality risk in acute ischemic stroke patients after endovascular therapy: evidence fr... by Yanping Lin (3639220)

    Published 2025
    “…Patients who died exhibited a progressive decline in eGFR (P < 0.05), while survivors showed a modest increase (P < 0.01). After comprehensive adjustment for confounders, each 1 mL/min/1.73 m<sup>2</sup> decrease in day-3 eGFR was associated with a 3% increase in mortality risk (P < 0.001); moderate-to-severe renal dysfunction (eGFR < 60 mL/min/1.73 m<sup>2</sup>) on day 3 was associated with a 4.3-fold increased risk of death (P < 0.001). …”
  15. 55

    Supplementary file 1_Comparative analysis of lipid metabolism in trophoblast subpopulations in preeclampsia and in vitro hypoxia model.pdf by Ivan Antipenko (22808513)

    Published 2025
    “…In vitro hypoxia modeling in BeWo b30 cells recapitulated the SCT-specific phenotype and identified a potential regulatory mechanism: a fivefold increase in PCSK9 expression (padj = 3.53e−10) and a 1.5-fold decrease in SNX17 (padj = 1.76e−04)—key regulators that limit lipoprotein receptor recycling. …”
  16. 56

    Table 1_Comparative analysis of lipid metabolism in trophoblast subpopulations in preeclampsia and in vitro hypoxia model.xlsx by Ivan Antipenko (22808513)

    Published 2025
    “…In vitro hypoxia modeling in BeWo b30 cells recapitulated the SCT-specific phenotype and identified a potential regulatory mechanism: a fivefold increase in PCSK9 expression (padj = 3.53e−10) and a 1.5-fold decrease in SNX17 (padj = 1.76e−04)—key regulators that limit lipoprotein receptor recycling. …”
  17. 57

    Table 2_Comparative analysis of lipid metabolism in trophoblast subpopulations in preeclampsia and in vitro hypoxia model.xlsx by Ivan Antipenko (22808513)

    Published 2025
    “…In vitro hypoxia modeling in BeWo b30 cells recapitulated the SCT-specific phenotype and identified a potential regulatory mechanism: a fivefold increase in PCSK9 expression (padj = 3.53e−10) and a 1.5-fold decrease in SNX17 (padj = 1.76e−04)—key regulators that limit lipoprotein receptor recycling. …”
  18. 58

    Table 3_Comparative analysis of lipid metabolism in trophoblast subpopulations in preeclampsia and in vitro hypoxia model.csv by Ivan Antipenko (22808513)

    Published 2025
    “…In vitro hypoxia modeling in BeWo b30 cells recapitulated the SCT-specific phenotype and identified a potential regulatory mechanism: a fivefold increase in PCSK9 expression (padj = 3.53e−10) and a 1.5-fold decrease in SNX17 (padj = 1.76e−04)—key regulators that limit lipoprotein receptor recycling. …”
  19. 59

    Table 4_Comparative analysis of lipid metabolism in trophoblast subpopulations in preeclampsia and in vitro hypoxia model.xlsx by Ivan Antipenko (22808513)

    Published 2025
    “…In vitro hypoxia modeling in BeWo b30 cells recapitulated the SCT-specific phenotype and identified a potential regulatory mechanism: a fivefold increase in PCSK9 expression (padj = 3.53e−10) and a 1.5-fold decrease in SNX17 (padj = 1.76e−04)—key regulators that limit lipoprotein receptor recycling. …”
  20. 60

    Chordoma preclinical models are insensitive to BAF complex inhibitor FHD-286, alone or in combination with gemcitabine by Chordoma Foundation (4391989)

    Published 2025
    “…Gemcitabine did not significantly increase sensitivity to FHD-286 in CH22 and UM-Chor1. …”